…ion, chronic or recurrent depression as adjunctive therapy, and rheumatoid arthritis, all commercially available as FDA approved systems. It is also…
relapsing-remitting multiple sclerosis
This disease is selected. Its supporting articles are shown below.
Articles mentioning relapsing-remitting multiple sclerosis
12 articles · page 1 of 1…s increasingly used as an outcome measure in clinical trials in relapsing-remitting multiple sclerosis (RRMS), but little is known about how chronological age interac…
…tained real-world effectiveness of natalizumab in patients with RRMS ( NCT00493298).…
…main alert to subjective neurological symptoms in patients with Huntington’s disease, ensuring that new manifestations are not automatically attribu…
…pport sustainable decision making and improve patient access in MS care.Conflict of Interest No conflict of interest…
…Background Evidence on relapse activity in relapsing-remitting multiple sclerosis (RRMS) after assisted reproductive technology (ART) treatment d…
…s two UK centres (Cardiff, Cambridge), we studied patients with RRMS who received at least 2 cycles of alemtuzumab and at least 1 fo…
…herapy of highly active relapsing-remitting multiple sclerosis (RRMS).Results 19 females and 4 males (age 40.96±9.91 years) were tre…
…lation cannot be recommend as a universal treatment strategy in RRMS. The decision to de-escalate should be considered on an individ…
…).Conclusions The seroconversion rate observed in patients with MS with low trough concentrations was substantially lower compared…
…Background The main goal of treatment in relapsing-remitting multiple sclerosis (RRMS) is to reduce the occurrence of relapses. However, little…
…Sweden (AutoMS-Swe) were analysed, comprising 174 patients with RRMS who received AHSCT before 1 January 2020. Primary outcomes incl…